Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-07-25 | Amended | $295,000 | $215,000 | Equity and Debt | 06c | SEC link |
| 2023-07-12 | New | $80,000 | $80,000 | Debt Only | 06c | SEC link |
| 2020-06-02 | Amended | $185,000 | $185,000 | Equity and Debt | 06c | SEC link |
| 2020-02-05 | New | $0 | $0 | Debt Only | 06b | SEC link |
| Name | Role |
|---|---|
| James Iversen | Director, Executive |
| Jacqueline Iversen | Executive |